Deutsche Bank has raised its target price for Siemens Energy amid comments about an accelerating investment cycle for the energy transition and the impression that the turnaround at wind turbine unit Siemens Gamesa “looks very much on track”
Subject to the exercise of the Option by Ambrose Healthcare, the agreement details clinical and commercial milestone payments to be made to ValiSeek totalling a value of up to £16 million plus royalties.
Under the licensing terms, Ambrose Healthcare commits to completing development and commercialisation of VAL401 at Ambrose's cost.